Found: 17
Select item for more details and to access through your institution.
Ruxolitinib in Metastatic Triple- Negative Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2018, p. 11
- By:
- Publication type:
- Article
First-Line Trastuzumab Plus an Aromatase Inhibitor, With or Without Pertuzumab, in HER2+ and HR+ Metastatic or Locally Advanced Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2018, p. 8
- By:
- Publication type:
- Article
Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer: MONARCH 2.
- Published in:
- Clinical Breast Cancer, 2017, p. 8
- By:
- Publication type:
- Article
Primary Metastatic Breast Cancer in the Era of Targeted Therapy-Prognostic Impact and the Role of Breast Tumor Surgery.
- Published in:
- Clinical Breast Cancer, 2017, p. 9
- By:
- Publication type:
- Article
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 10, p. 7913, doi. 10.1007/s00520-022-07226-9
- By:
- Publication type:
- Article
A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6135, doi. 10.1007/s00520-022-07025-2
- By:
- Publication type:
- Article
Evolving Considerations in the Management of HER2-Positive Advanced Breast Cancer: Individualized Treatments for Improved Clinical and Economic Outcomes.
- Published in:
- Journal of Managed Care Medicine, 2023, v. 26, n. 1, p. 49
- By:
- Publication type:
- Article
Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211041961
- By:
- Publication type:
- Article
Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211041961
- By:
- Publication type:
- Article
Individualizing Extended Adjuvant Therapy in HR+ Breast Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 350
- By:
- Publication type:
- Article
Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse.
- Published in:
- Breast Cancer: Basic & Clinical Research, 2015, n. 9, p. 9, doi. 10.4137/BCBCR.S23794
- By:
- Publication type:
- Article
A role for fulvestrant monotherapy in the first‐line treatment of ER+ metastatic breast cancer?
- Published in:
- Breast Journal, 2020, v. 26, n. 2, p. 109, doi. 10.1111/tbj.13495
- By:
- Publication type:
- Article
Insomnia in the Cancer Patient: A Complex Problem.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 513, doi. 10.2147/CMAR.S186658
- By:
- Publication type:
- Article
Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 249, doi. 10.2147/CMAR.S150960
- By:
- Publication type:
- Article
Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 414, doi. 10.1093/oncolo/oyad021
- By:
- Publication type:
- Article
Synergy Between Cetuximab and Chemotherapy in Tumors of the Gastrointestinal Tract.
- Published in:
- Oncologist, 2008, v. 13, n. 1, p. 1, doi. 10.1634/theoncologist.2006-0049
- By:
- Publication type:
- Article